FDA Inspection 867474 — Seagren, Dr Jonathan E
The FDA completed an inspection of Seagren, Dr Jonathan E on March 12, 2014 in Oakland, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oakland, NE (United States)
Additional Details
Clinical Investigator (CI)